A randomized trial of aripiprazole vs blonanserin for the treatment of acute schizophrenia and related disorders

OBJECTIVE: There has been no direct comparison of aripiprazole and blonanserin for schizophrenia treatment. We conducted a 24-week, rater-masked, randomized trial of aripiprazole (6−30 mg/d) vs blonanserin (4−24 mg/d) in schizophrenia patients who were not taking any antipsychotic medication for mor...

Descripción completa

Detalles Bibliográficos
Autores principales: Kishi, Taro, Matsuda, Yuki, Matsunaga, Shinji, Mukai, Tomohiko, Moriwaki, Masatsugu, Tabuse, Hideaki, Fujita, Kiyoshi, Iwata, Nakao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135406/
https://www.ncbi.nlm.nih.gov/pubmed/27932884
http://dx.doi.org/10.2147/NDT.S121588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135406/
https://www.ncbi.nlm.nih.gov/pubmed/27932884
http://dx.doi.org/10.2147/NDT.S121588

Ejemplares similares